Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0072 | 0.9 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |